feed,title,long_url,short_url
ðŸ’°Barrons,Novo Nordisk to Pay Up to $2 Billion to License Chinese Companyâ€™s Weight-Loss Drug,https://barrons.com/articles/novo-nordisk-stock-china-ozempic-2c2bfcf6?mod=RTA,https://da.gd/NGh0DF
